Estrogen Receptor Testing of Breast Cancer in Current Clinical Practice: What's the Question?-Reference-Cited by-同舟云学术

Estrogen Receptor Testing of Breast Cancer in Current Clinical Practice: What's the Question?

Published:2006-04-20 Issue:12 Volume:24 Page:1797-1799
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Schnitt Stuart J.¹

Affiliation:

1. From the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.0666

Reference31 articles.

1. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155,1998-168,

2. Estrogen Receptor Analysis for Breast Cancer

3. Elledge RM, Allred DC: Clinical aspects of estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast (ed 3). Philadelphia, PA, Lippincott Williams and Wilkins, pp 603,2004-617

4. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

5. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional confirmation of successful cell suspension fractionation of metastatic axillary node tissue;Pathology - Research and Practice;2024-08

2. Western Blot analysis confirms nuclear localization of nodal ERα and PRB protein biomarkers in fractionated axillary node-positive breast cancer tissue: A Case Report;2023-09-28

3. Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region;JNCI: Journal of the National Cancer Institute;2021-09-11

4. Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer;Breast Cancer Research and Treatment;2019-04-17

5. Comparison of Different Scoring Systems in the Assessment of Estrogen Receptor Status for Predicting Prognosis in Endometrial Cancer;International Journal of Gynecological Pathology;2019-03